Biologists at Mapp Biopharmaceuticals in San Diego have gone public with formal results that point to a possible cure for the Ebola virus. Utilizing their collective creativity, they have deemed this "monumental achievement" ZMapp.
In trials done with rhesus monkeys, ZMapp cured 100% of the monkeys infected with the Ebola virus. They even waited until five days after contamination and the results remained. This is comparable to the control group where all monkeys died within three days of infection.
The importance of these results is escalated because of the recent outbreak of Ebola in West Africa. According to USA Today, 3,000 people have been infected with the disease as a result, and about half have died. Two Americans have also been victims, although both survived after receiving medical treatment in the United States.
There is, however, one caveat. The strain that is plunging through Africa is a different strain of the Ebola virus than the one used in the ZMapp trials. Mapp Biopharmaceuticals says that they remain optimistic because ZMapp was able to have the same effect on the West Africa strain in test tube trials.
Read the full story here